< Back to latest news & events

Event

Challenging granted patents: a comparison between Europe and the US

October 2021

Event date: 3rd November 2021

HGF and Knobbe Martens are holding a webinar on 3rd November.

Challenging granted patents: a comparison between Europe and the US

In this webinar we will compare and contrast mechanisms for challenging patents in both Europe and the US. In particular, we will focus on opposition proceedings before the European Patent Office (EPO) along with proceedings at the Patent Trial and Appeal Board (PTAB) in the US. Comparisons will be made between each of the jurisdictions illustrated by case studies as examples. Additionally, the panel will provide practical tips on how to maximize the chance of success in each jurisdiction.

This webinar will cover:

  • An outline of the European opposition process and PTAB trials process in the US generally, including inter partes review (IPR) and post-grant review (PGR)
  • Tactical considerations and approach prior to filing an opposition in Europe or a petition for IPR/PGR in the US
  • Discussion of key differences between European and the US invalidity proceedings
  • Practice updates from Europe, including the use of videoconferencing for oral proceedings and changes to the Rules of Procedure at the Boards of Appeal
  • Practice updates from the US, including discretionary denials and the many challenges to the NHK-Fintiv rule, which may block IPRs when co-pending litigation exists
  • Strategy considerations in deciding whether to challenge a U.S. patent versus a European patent.
Speakers

Attendees

Latest updates

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Read article

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Read article
Event - 5th November 2025

HGF are Gold Sponsors of IAM Live: Navigating the UPC 2025

We’re excited to share that HGF is a Gold Sponsor of IAM Live: Navigating the UPC 2025, taking place on the 5th November at the Marriott Opera Ambassador Hotel in …

Event details

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article

T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

The EPO Board of Appeal’s decision in T 0792/24 provides helpful guidance on the assessment of novelty and inventive step for European second medical use claims. In light of a …

Read article